RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Investing gives you the opportunity to grow your money, to help you get the most out of life, whatever goals you have in mind ...

GE Vernova's shares hit a new intraday high of over $407 on Tuesday, bolstered by investor confidence despite recent political developments. RBC Capital analysts ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

BCE's Ziply acquisition presents growth, despite risks and potential dividend cuts. Read why BCE stock offers long-term ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Real estate investment trusts (REITs) allow investors to invest in commercial real estate without actually buying and managing properties themselves. Many, or all, of the products featured on this ...

TIPS keep looking better and better. So-called TIPS bonds — the acronym stands for “Treasury inflation-protected securities” — are the only asset legally protected against the risks of ...

The group joining RBC's New York City office, led by advisors formerly affiliated with First Republic, gives it an additional ...

Long-term US Treasury yields have climbed so quickly that a prominent bear has said it’s time to take some chips off the table.